tiprankstipranks
Trending News
More News >
Cell Source Inc (CLCS)
OTHER OTC:CLCS
US Market

Cell Source (CLCS) Financial Statements

Compare
11 Followers

Cell Source Financial Overview

Cell Source's market cap is currently $34.04M. The company's EPS TTM is $-0.161; its P/E ratio is -5.78; Cell Source is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -3.85M$ -4.33M$ -4.17M$ -4.02M$ -3.64M
EBITDA$ -3.60M$ -4.22M$ 0.00$ -93.00K$ -3.62M
Net Income$ -4.77M$ -5.32M$ -5.17M$ -5.47M$ -4.56M
Balance Sheet
Cash & Short-Term Investments$ 74.63K$ 22.20K$ 222.66K$ 93.09K$ 245.12K
Total Assets$ 286.50K$ 195.17K$ 409.85K$ 313.77K$ 452.34K
Total Debt$ 10.07M$ 9.25M$ 7.90M$ 6.47M$ 4.81M
Net Debt$ 9.99M$ 9.23M$ 7.68M$ 6.38M$ 4.56M
Total Liabilities$ 19.08M$ 15.81M$ 13.04M$ 10.14M$ 8.40M
Stockholders' Equity$ -18.80M$ -15.61M$ -12.63M$ -9.83M$ -7.95M
Cash Flow
Free Cash Flow$ -2.68M$ -2.35M$ -3.14M$ -3.38M$ -2.77M
Operating Cash Flow$ -2.68M$ -2.35M$ -3.14M$ -3.38M$ -2.77M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 2.74M$ 2.15M$ 3.27M$ 3.23M$ 2.99M
Currency in USD

Cell Source Earnings and Revenue History

Cell Source Debt to Assets

Cell Source Cash Flow

Cell Source Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.